Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2194-7511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection ; volume:8 ; number:1 ; day:4 ; month:7 ; year:2020 ; pages:1-17 ; date:12.2020
International Journal of Bipolar Disorders ; 8, Heft 1 (4.7.2020), 1-17, 12.2020
- Creator
-
Cuéllar-Barboza, Alfredo B.
McElroy, Susan L.
Veldic, Marin
Singh, Balwinder
Kung, Simon
Romo-Nava, Francisco
Nunez, Nicolas A.
Cabello-Arreola, Alejandra
Coombes, Brandon J.
Prieto, Miguel
Betcher, Hannah K.
Moore, Katherine M.
Winham, Stacey J.
Biernacka, Joanna
Frye, Mark A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40345-020-00184-3
- URN
-
urn:nbn:de:101:1-2020090521493350176605
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cuéllar-Barboza, Alfredo B.
- McElroy, Susan L.
- Veldic, Marin
- Singh, Balwinder
- Kung, Simon
- Romo-Nava, Francisco
- Nunez, Nicolas A.
- Cabello-Arreola, Alejandra
- Coombes, Brandon J.
- Prieto, Miguel
- Betcher, Hannah K.
- Moore, Katherine M.
- Winham, Stacey J.
- Biernacka, Joanna
- Frye, Mark A.
- SpringerLink (Online service)
Other Objects (12)
Bipolar disorder
Smartphone-based objective monitoring in bipolar disorder: status and considerations
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
User considerations in assessing pharmacogenomic tests and their clinical support tools
Genetics of bipolar disorder
P04.10. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
The clinical trajectory of emerging bipolar disorder among the high-risk offspring of bipolar parents: current understanding and future considerations
Big data for bipolar disorder
Evaluating endophenotypes for bipolar disorder
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
Bipolar disorder
Smartphone-based objective monitoring in bipolar disorder: status and considerations
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
User considerations in assessing pharmacogenomic tests and their clinical support tools
Genetics of bipolar disorder
P04.10. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
The clinical trajectory of emerging bipolar disorder among the high-risk offspring of bipolar parents: current understanding and future considerations
Big data for bipolar disorder
Evaluating endophenotypes for bipolar disorder
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
Bipolar disorder
Smartphone-based objective monitoring in bipolar disorder: status and considerations
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
User considerations in assessing pharmacogenomic tests and their clinical support tools
Genetics of bipolar disorder
P04.10. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
The clinical trajectory of emerging bipolar disorder among the high-risk offspring of bipolar parents: current understanding and future considerations
Big data for bipolar disorder
Evaluating endophenotypes for bipolar disorder